81
Views
24
CrossRef citations to date
0
Altmetric
Original Research

Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles

, , , , , , , , & show all
Pages 899-909 | Published online: 27 Jan 2017

References

  • KooHHuhMSSunICIn vivo targeted delivery of nanoparticles for theranosisAcc Chem Res201144101018102821851104
  • KircherMFMahmoodUKingRSWeisslederRJosephsonLA multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineationCancer Res200363238122812514678964
  • CormodeDPSkajaaTvan SchooneveldMMNanocrystal core high-density lipoproteins: a multimodality contrast agent platformNano Lett20088113715372318939808
  • LinJ-JChenJ-SHuangS-JFolic acid–pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applicationsBiomaterials200930285114512419560199
  • KeJ-HLinJ-JCareyJRChenJ-SChenC-YWangL-FA specific tumor-targeting magnetofluorescent nanoprobe for dual-modality molecular imagingBiomaterials20103171707171519969347
  • PittetMJSwirskiFKReynoldsFJosephsonLWeisslederRLabeling of immune cells for in vivo imaging using magnetofluorescent nanoparticlesNat Protoc200611737917406214
  • DevarajNKKeliherEJThurberGMNahrendorfMWeisslederR18F labeled nanoparticles for in vivo PET-CT imagingBioconjug Chem200920239740119138113
  • SongH-TJordanEKLewisBKRat model of metastatic breast cancer monitored by MRI at 3 Tesla and bioluminescence imaging with histological correlationJ Transl Med200978819840404
  • LohrkeJFrenzelTEndrikatJ25 years of contrast-enhanced MRI: developments, current challenges and future perspectivesAdv Ther201633112826809251
  • PhamBTTJainNKuchelPWThe interaction of sterically stabilized magnetic nanoparticles with fresh human red blood cellsInt J Nanomedicine2015106645665526604741
  • EamegdoolSSWeibleMW2ndPhamBTTHawkettBSGrieveSMChan-lingTUltrasmall superparamagnetic iron oxide nanoparticle prelabelling of human neural precursor cellsBiomaterials201435215549556424726535
  • Torres Martin de RosalesRTavaréRGlariaAVarmaGProttiABlowerPJ99mTc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imagingBioconjug Chem201122345546521338098
  • HahnMASinghAKSharmaPBrownSCMoudgilBMNanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectivesAnal Bioanal Chem2011399132720924568
  • WehrlHFJudenhoferMSWiehrSPichlerBJPre-clinical PET/MR: technological advances and new perspectives in biomedical researchEur J Nucl Med Mol Imaging200936suppl 1S56S6819194703
  • WadasTJWongEHWeismanGRAndersonCJCoordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of diseaseChem Rev201011052858290220415480
  • WernerRABluemelCAllen-AuerbachMSHiguchiTHerrmannK(68)Gallium- and (90)Yttrium-/(177)Lutetium: “theranostic twins” for diagnosis and treatment of NETsAnn Nucl Med2015291725139472
  • StelterLPinkernelleJGMichelRModification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imagingMol Imaging Biol2010121253419582510
  • ThorekDLJUlmertDDiopN-FMNon-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticleNat Commun20145309724445347
  • KiesslingFMertensMEGrimmJLammersTNanoparticles for imaging: top or flop?Radiology20142731102825247562
  • ErranteYCirimeleVMallioCADi LazzaroVZobelBBQuattrocchiCCProgressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelationInvest Radiol2014491068569024872007
  • KandaTIshiiKKawaguchiHKitajimaKTakenakaDHigh signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast materialRadiology2014270383484124475844
  • FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol) Published March 30, 2015US Department of Health and Human Services; US Food and Drug Administration Available from: http://www.fda.gov/Drugs/DrugSafety/ucm440138.htmAccessed January 11, 2017
  • StendahlJCSinusasAJNanoparticles for cardiovascular imaging and therapeutic delivery, part 1: compositions and featuresJ Nucl Med201556101469147526272808
  • BryceNSPhamBTTFongNWSThe composition and end-group functionality of sterically stabilized nanoparticles enhances the effectiveness of co-administered cytotoxinsBiomater Sci201311212601272
  • PhamBTTSuchCHHawkettBSSynthesis of polymeric Janus nanoparticles and their application in surfactant-free emulsion polymerizationsPolym Chem201563426435
  • NormandinMDYuanHWilksMQHeat-induced radiolabeling of nanoparticles for monocyte tracking by PETAngew Chem Int Ed Engl20155444130021300626368132
  • BorosEBowenAMJosephsonLVasdevNHollandJPChelate-free metal ion binding and heat-induced radiolabeling of iron oxide nanoparticlesChem Sci201561225236
  • ŠčasnárVLierJEThe use of SEP-PAK Sl cartridges for the preparation of gallium chloride from the citrate solutionEur J Nucl Med Mol Imaging19932031